Related references
Note: Only part of the references are listed.Ablative Approaches for Pulmonary Metastases
Matthew J. Boyer et al.
THORACIC SURGERY CLINICS (2016)
Stereotactic Body Radiation Therapy for Oligometastases to the Lung: A Phase 2 Study
Joost J. Nuyttens et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch® patient registry
Joanne N. Davis et al.
RADIATION ONCOLOGY (2015)
Stereotactic radiotherapy for oligometastatic cancer: a prognostic model for survival
T. de Vin et al.
ANNALS OF ONCOLOGY (2014)
An Individual Patient Data Metaanalysis of Outcomes and Prognostic Factors After Treatment of Oligometastatic Non-Small-Cell Lung Cancer
Allison B. Ashworth et al.
CLINICAL LUNG CANCER (2014)
The RSSearch™ Registry: patterns of care and outcomes research on patients treated with stereotactic radiosurgery and stereotactic body radiotherapy
Joanne N. Davis et al.
RADIATION ONCOLOGY (2013)
Feasibility and toxicity of hypofractionated image guided radiation therapy for large volume limited metastatic disease
Kimberly S. Corbin et al.
PRACTICAL RADIATION ONCOLOGY (2013)
Stereotactic body radiotherapy for multisite extracranial oligometastases Final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease
Joseph K. Salama et al.
CANCER (2012)
Stereotactic body radiation therapy for lung metastases
Umberto Ricardi et al.
LUNG CANCER (2012)
Review and Uses of Stereotactic Body Radiation Therapy for Oligometastases
Filippo Alongi et al.
ONCOLOGIST (2012)
Oligo- and Polymetastatic Progression in Lung Metastasis(es) Patients Is Associated with Specific MicroRNAs
Yves A. Lussier et al.
PLOS ONE (2012)
Resection of liver metastases from breast cancer: Estrogen receptor status and response to chemotherapy before metastasectomy define outcome
Daniel E. Abbott et al.
SURGERY (2012)
MicroRNA Expression Characterizes Oligometastasis(es)
Yves A. Lussier et al.
PLOS ONE (2011)
Stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer and other primary cancers in comparison with primary lung cancer
Atsuya Takeda et al.
RADIOTHERAPY AND ONCOLOGY (2011)
Local Control of Metastatic Lung Tumors Treated with SBRT of 48 Gy in Four Fractions: In Comparison with Primary Lung Cancer
Yasushi Hamamoto et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2010)
DOSE-RESPONSE RELATIONSHIP FOR IMAGE-GUIDED STEREOTACTIC BODY RADIOTHERAPY OF PULMONARY TUMORS: RELEVANCE OF 4D DOSE CALCULATION
Matthias Guckenberger et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
OBSERVATION OF A DOSE-CONTROL RELATIONSHIP FOR LUNG AND LIVER TUMORS AFTER STEREOTACTIC BODY RADIATION THERAPY
Robert McCammon et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions
Michael T. Milano et al.
CANCER (2008)
Stereotactic body radiotherapy for oligometastatic lung tumors
Yoshiki Norihisa et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: A systematic review and pooled analysis
Tawee Tanvetyanon et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Clinical results of stereotactic body frame based fractionated radiation therapy for primary or metastatic thoracic tumors
Sang Min Yoon et al.
ACTA ONCOLOGICA (2006)
Stereotactic body radiation therapy (SBRT) for lung metastases
Paul Okunieff et al.
ACTA ONCOLOGICA (2006)
Dose-response in stereotactic irradiation of lung tumors
J Wulf et al.
RADIOTHERAPY AND ONCOLOGY (2005)
Share Paper
